Journey Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Journey Medical generated cash of $5,240,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,804,000 last year. Net change in cash is therefore -$4,564,000.
Cash Flow
| 2014 | -31.40M | -109.48M | 174.09M |
|---|---|---|---|
| 2015 | -48.44M | -2.60M | 102.92M |
| 2016 | -74.11M | -130.28M | 138.95M |
| 2017 | -103.96M | -104.43M | 462.52M |
| 2018 | -213.09M | -13.22M | 35.38M |
| 2019 | 9.01M | -2.4M | -3.55M |
| 2020 | 5.13M | -1.2M | -487K |
| 2021 | -2.18M | -10M | 53.01M |
| 2022 | -13.53M | -20M | 16.45M |
| 2023 | 5.24M | -5M | -4.80M |
DERM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 32.00M | 49.08M | 8.24M | 4.80M | 1.73M | 295.92M | 41.79M | 107.24M | 55.35M | 22.14M |
Operating activities | ||||||||||
Net income | -3.85M | -29.62M | -43.99M | 5.28M | 3.62M | -221.54M | -303.26M | -89.08M | -78.39M | -31.87M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.85M | 4.36M | 2.56M | 1.51M | 1.26M | 555K | 339K | 123K | 72K | 47K |
Stock-based compensation expense | 2.60M | 4.42M | 2.46M | 153K | 240K | 0 | 20.70M | 0 | 5.13M | 0 |
| Deferred income tax benefit | 2.60M | 4.42M | 2.46M | 153K | 240K | 0 | 20.70M | 0 | 5.13M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 12.55M | -5.38M | 768K | -5.02M | -10.49M | -5.67M | 21.34M | -21.4M | 7.3M | -7.3M |
Inventories | 3.95M | 1.74M | -8.45M | -547K | -179K | -8.37M | -271.88M | -174.20M | -104.48M | -91.02M |
Accounts payable | -18.42M | 14.34M | 21.71M | -152K | 1.14M | 823K | 1.54M | 4.26M | 3.60M | 3.20M |
Cash generated by operating activities | 5.24M | -13.53M | -2.18M | 5.13M | 9.01M | -213.09M | -103.96M | -74.11M | -48.44M | -31.40M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -319.94M | -302.43M | -252.17M | -60.27M | -109.32M |
Investments In Property Plant And Equipment | 0 | -20M | -10M | -1.2M | -2.4M | -616K | -278K | -753K | -202K | -156K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130.28M | 0 | 0 |
Cash generated by investing activities | -5M | -20M | -10M | -1.2M | -2.4M | -13.22M | -104.43M | -130.28M | -2.60M | -109.48M |
Financing activities | ||||||||||
Common Stock Issued | 4.49M | -371K | 32.53M | 13K | 0 | 2.14M | 181.53M | 138.95M | 105.04M | 11K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -371K | -1.55M | 0 | 0 | 2.14M | 184.27M | 138.95M | 105.04M | 170.08M |
Repayments of term debt | -8.94M | 16.89M | -11.48M | -500K | -3.55M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -4.80M | 16.45M | 53.01M | -487K | -3.55M | 35.38M | 462.52M | 138.95M | 102.92M | 174.09M |
Net Change In Cash | -4.56M | -17.07M | 40.83M | 3.44M | 3.06M | -190.94M | 254.13M | -65.44M | 51.88M | 11.07M |
Cash at end of period | 27.43M | 32.00M | 49.08M | 8.24M | 4.80M | 104.97M | 295.92M | 41.79M | 107.24M | 33.21M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |